اثرات ویتیوکسکتین بر عملکرد شناختی در بیماران مبتلا به اختلال افسردگی عمده: یک مطالعه اکتشافی کوتاه مدت، تصادفی، دو سو کور

This explorative study showed no significant differences versus placebo in DSST or UPSA-B performance at week 8. However, secondary results support vortioxetine as an effective and well-tolerated antidepressant, supporting an added benefit for cognition and functioning, which could have particular therapeutic relevance for the working patient population.